Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.560
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.59 billion as of April 28, 2026. Its market cap has increased by 167.01% in one year.
Market Cap
1.59B
Enterprise Value
1.12B
1-Year Change
167.01%
Ranking
Category
Stock Price
$4.56
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.59B, an increase of 809.67%. That is a compound annual growth rate of 47.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.59B | -48.39% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.78B |
| Palvella Therapeutics | 1.77B |
| Rapport Therapeutics | 1.75B |
| Innoviva | 1.75B |
| Nurix Therapeutics | 1.72B |
| Sionna Therapeutics | 1.71B |
| AnaptysBio | 1.69B |
| AtaiBeckley | 1.69B |